Marburg Virus Disease in Rwanda, 2024 - Public Health and Clinical Responses.
Nsanzimana S, Remera E, Nkeshimana M, Westergaard RP, Firew T, Semakula M, Seruyange E, Neil KL, Kreuger MJ, Bekele A, Biramahire J, Bizimana A, Chirombo B, Diaz J, Dushimimana G, Fischer WA 2nd, Fletcher TE, Fowler R, Gatera MR, Giuliani R, Goldberg J, Hakorimana F, Hatchett R, Ingabire Z, Ingabire L, Ishimwe A, Isingizwe G, Jacquerioz F, Kayigi E, Kazindu S, Manirafasha A, Mills EJ, Mugabo H, Mukagatare I, Murayire J, Musanabaganwa C, Mushuru E, Mutesa L, Muvunyi CM, Muvunyi R, Mwiseneza L, Nahayo E, Ndayiragije V, Ndayisabye H, Ndayishimiye GS, Ngabonziza JCS, Niwemuhoza MG, Niyigaba N, Niyonshuti P, Niyonizeye MG, Nsekuye O, Ntakambirwa DK, Ntawuyirusha E, Ntihumbya JB, Nyirigira G, Rojek A, Rukundo A, Rwabihama JP, Rwamwejo F, Shumbusho G, Sibomana JP, Turatsinze D, Uwamahoro DL, Uwimana FX, Butera Y, Twagirumugabe T, Rwagasore E; Rwanda MVD Outbreak Response Team.
Nsanzimana S, et al.
N Engl J Med. 2025 Sep 11;393(10):983-993. doi: 10.1056/NEJMoa2415816.
N Engl J Med. 2025.
PMID: 40929633
